RxDestruct Overview
- Founded
- 2009
- Status
- Private
- Employees
- 7
- Latest Deal Type
- Series A
- Latest Deal Amount
- $2.45M
- Investors
- 5
RxDestruct General Information
Description
Developer of a waste management system designed to help hospitals and nursing homes to dispose of their pharmaceutical waste safely and conveniently. The company's product helps in neutralizing the active compounds in unused medications so they can be disposed of easily without polluting water supplies, enabling hospitals to ensure pharmaceutical waste stays out of the environment and does not contribute to the current opioid epidemic sweeping the country.
Contact Information
Website
www.rxdestruct.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Environmental Services (B2B)
Other Industries
Electrical Equipment
Primary Office
- 106 Capri Street
- Sugar Land, TX 77478
- United States
RxDestruct Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 03-Jun-2020 | $2.45M | 00.000 | 00.000 | Completed | Generating Revenue |
| 3. Angel (individual) | 24-Oct-2013 | 00000 | Completed | Startup | ||
| 2. Angel (individual) | 14-Nov-2011 | $342K | $342K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
RxDestruct Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
RxDestruct Patents
RxDestruct Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210047210-A1 | Flow apparatus for treating pharmaceutical waste | Pending | 13-Aug-2019 | 0000000000 | |
| US-11053145-B2 | Apparatus for treating pharmaceutical waste | Active | 19-Dec-2012 | 000000000 | 00 |
| US-20180346359-A1 | Apparatus for treating pharmaceutical waste | Granted | 19-Dec-2012 | 000000000 | |
| CA-2895214-A1 | Apparatus for treating pharmaceutical waste | Pending | 19-Dec-2012 | 000000000 | |
| US-10046993-B2 | Apparatus for treating pharmaceutical waste | Active | 19-Dec-2012 | C02F1/722 | 0 |
RxDestruct Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Macdonell | Chief Executive Officer & Board Member | ||
| Thomas Stern | Co-Founder & Executive Vice President of Sales |
RxDestruct Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Chris Cuzalina | Self | Board Member & Advisor | 000 0000 |
| Chris Quinn | RxDestruct | Board Member | 000 0000 |
| Mark Macdonell | RxDestruct | Chief Executive Officer & Board Member | 000 0000 |
| Michael Sanborn | RxDestruct | Board Member | 000 0000 |
| Scott Kosch | RxDestruct | Board Member | 000 0000 |
RxDestruct Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRxDestruct Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Cascata Capital Management | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| i2E | Venture Capital | Minority | 000 0000 | 000000 0 | |
| SeedStep Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Scott Kosch | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Insight Accelerator Labs | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |